After confirming that cohort characteristics were comparable, we analyzed the IgM N-glycosylation profiles from day 4 and 7 hospitalized COVID-19 IMPACC patients across illness severity (Fig. 1c). The gene discussed is CD40LG; the disease is COVID-19.